X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/15/2863205/16626/en/Zevra-Therapeutics-Presents-New-Data-on-the-Long-Term-Safety-and-Efficacy-of-Arimoclomol-as-a-Treatment-for-Niemann-Pick-Disease-Type-C-at-the-SIMD-45th-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/04/10/2860662/16626/en/Zevra-Therapeutics-Refinances-Existing-Debt-with-up-to-100M-in-Committed-Capital-under-New-Credit-Facility.html
https://www.globenewswire.com/news-release/2024/03/28/2854508/16626/en/Zevra-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Corporate-Updates.html
https://www.globenewswire.com/news-release/2024/03/26/2852762/16626/en/Zevra-Therapeutics-Announces-Top-Line-Data-from-the-Phase-2-Clinical-Trial-of-KP1077-for-Idiopathic-Hypersomnia.html
https://www.globenewswire.com/news-release/2024/03/25/2852011/16626/en/Zevra-Therapeutics-to-Present-at-the-23rd-Annual-Needham-Virtual-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/03/18/2847700/16626/en/Zevra-Therapeutics-to-Report-2023-Fourth-Quarter-and-Full-Year-Financial-Results-on-March-28-2024.html
https://www.globenewswire.com//news-release/2024/03/04/2839444/16626/en/Zevra-Therapeutics-Provides-FDA-Update-on-the-PDUFA-Action-Date-for-Arimoclomol-as-a-Treatment-for-Niemann-Pick-Disease-Type-C.html
https://www.globenewswire.com//news-release/2024/02/28/2836855/16626/en/Zevra-Therapeutics-to-Participate-at-Upcoming-Investor-Conferences.html
https://www.globenewswire.com//news-release/2024/02/06/2824183/16626/en/Zevra-Therapeutics-to-Present-at-the-Oppenheimer-34th-Annual-Healthcare-Life-Sciences-Conference.html
https://www.globenewswire.com//news-release/2024/01/23/2813979/16626/en/Zevra-Therapeutics-Appoints-Experienced-Biopharma-Executive-Alvin-Shih-MD-MBA-to-the-Board-of-Directors.html
Market Place
Share 
